Jensen Ashley W, Viozzi Christopher F, Foote Robert L
Mayo School of Graduate Medical Education, Mayo Clinic, Rochester, MN 55905, USA.
J Oral Maxillofac Surg. 2010 May;68(5):1100-5. doi: 10.1016/j.joms.2009.12.018. Epub 2010 Feb 24.
To assess the long-term efficacy and toxicity of radiation therapy (RT) for postoperative prophylaxis of recurrent heterotopic ossification (HO) in the temporomandibular joint (TMJ).
Twelve patients (18 joints) with bony ankylosis of the TMJ from HO were referred to undergo RT after arthrotomy with osseous recontouring, gap arthroplasty, or costochondral grafting. Treatment consisted of 10 Gy in 5 daily fractions to a field encompassing the TMJ with an adequate margin. RT was initiated 1 to 3 days postoperatively. Response to therapy was assessed by routine x-ray films obtained preoperatively, immediately postoperatively, and at follow-up by use of the Turlington-Durr grading system. Treatment efficacy was defined as freedom from HO re-formation requiring further surgical intervention. Efficacy and toxicity data were obtained from review of the medical records and were augmented by telephone interview of patients when possible (6 patients, all with follow-up >16 years). Efficacy rates by patient were estimated by the Kaplan-Meier method.
The median follow-up after RT was 16.4 years (range, 2.5-19.2 years). Symptomatic re-formation of HO requiring further surgery occurred in 5 patients (7 joints). Treatment efficacy rates were 71% (95% confidence interval [CI], 44-99) at 5 years and 48% (95% CI, 15-80) at 10 years. Of the 6 patients contacted regarding late toxicity, 2 had clinical xerostomia (grade 1, CTCAE v3.0) attributable to RT; no other late RT-related toxicities were noted. None of the 12 patients had malignancy attributable to RT.
Postoperative RT prevented re-formation of TMJ HO in 50% of treated patients long term. Late toxicities from RT were mild and infrequent.
评估放射治疗(RT)对颞下颌关节(TMJ)术后复发性异位骨化(HO)预防的长期疗效和毒性。
12例因HO导致TMJ骨性强直的患者(18个关节),在接受关节切开术联合骨轮廓重塑、间隙关节成形术或肋软骨移植术后,被转诊接受RT治疗。治疗方案为每日5次分割剂量,每次2 Gy,照射包含TMJ并带有足够边界的区域。RT于术后1至3天开始。通过术前、术后即刻以及随访时获取的常规X线片,采用Turlington-Durr分级系统评估治疗反应。治疗疗效定义为无需进一步手术干预的HO未再形成。疗效和毒性数据通过查阅病历获得,并在可能的情况下通过电话访谈患者进行补充(6例患者,均随访超过16年)。患者的疗效率采用Kaplan-Meier法估算。
RT后的中位随访时间为16.4年(范围2.5 - 19.2年)。5例患者(7个关节)出现需要进一步手术的有症状的HO再形成。5年时的治疗有效率为71%(95%置信区间[CI],44 - 99),10年时为48%(95% CI,15 - 80)。在就晚期毒性联系的6例患者中,2例有因RT导致的临床口干(1级,CTCAE v3.0);未观察到其他与RT相关的晚期毒性。12例患者中无一例因RT发生恶性肿瘤。
术后RT长期预防了50%接受治疗患者的TMJ HO再形成。RT的晚期毒性轻微且不常见。